Who is my brother's keeper?

Area of Science:

• Global Health Ethics
• Bioethics
• International Research Standards

Background:

• Developed countries implement clinical and research practices in developing nations.
• Justifications for these practices include placebo use, unapproved drug distribution, withholding therapy, and denying post-trial benefits.
• These practices often contradict ethical standards in developed nations and the Declaration of Helsinki.

Purpose of the Study:

• To critique bioethical arguments that support less stringent ethical standards in international clinical and research practices.
• To challenge the justification of double ethical standards in medical and pharmaceutical practices, research strategies, and the application of research results.
• To advocate for the universal application of ethical standards in global health research.

Main Methods:

• Literature review and critical analysis of bioethical arguments.
• Examination of justifications for differential ethical standards in clinical and research practices.
• Analysis of arguments concerning placebo use, drug approval, and post-trial benefits.

Main Results:

• The paper identifies and critiques arguments that defend lower ethical standards in research conducted in developing countries.
• It highlights the inconsistency of these practices with ethical guidelines like the Declaration of Helsinki.
• The analysis reveals a trend of bioethicists providing justifications for exceptions to universal ethical norms.

Conclusions:

• There is a need to challenge and reject ad hoc arguments that permit lower ethical standards in research in developing nations.
• Universal ethical standards must be upheld in all clinical and research practices, regardless of geographic location.
• Scholars should promote the universalizability of ethics rather than defending ethically questionable exceptions.